CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →UCSD Sanford Stem Cell Institute
Grant: NA
National Institute of Dental and Craniofacial Research
Grant: U01DE028227
National Cancer Institute
Grant: R01CA247551
National Cancer Institute
Grant: U01CA217885
National Institutes of Health
Grant: CRI3792
National Institutes of Health
Grant: F32DE029990-01
NIDCR NIH HHS
Grant: F32 DE029990
NCI NIH HHS
Grant: P30 CA023100
National Institutes of Health
Grant: 5U01DE028227-03
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
National Institutes of Health
Grant: 3P30CA023100-25S4
Specialized Cancer Center Support Grant
National Institutes of Health
Grant: 1F32DE029990-01
Exploiting the HER3-PI3K/mTOR-Immune Axis to Design Precision Immune Oncology Therapy for Head & Neck Cancer
National Institutes of Health
Grant: 5U01CA217885-03
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
National Institutes of Health
Grant: 5R01CA247551-04
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
FWCI
0.91
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals